701 related articles for article (PubMed ID: 25385105)
1. Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
Brizendine KD; Richter SS; Cober ED; van Duin D
Antimicrob Agents Chemother; 2015 Jan; 59(1):553-7. PubMed ID: 25385105
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Wu D; Cai J; Liu J
South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
[TBL] [Abstract][Full Text] [Related]
4. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
Ny P; Nieberg P; Wong-Beringer A
Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
[TBL] [Abstract][Full Text] [Related]
5. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.
Espinar MJ; Miranda IM; Costa-de-Oliveira S; Rocha R; Rodrigues AG; Pina-Vaz C
PLoS One; 2015; 10(8):e0134737. PubMed ID: 26237422
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
[TBL] [Abstract][Full Text] [Related]
7. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.
Qureshi ZA; Syed A; Clarke LG; Doi Y; Shields RK
Antimicrob Agents Chemother; 2014 Jun; 58(6):3100-4. PubMed ID: 24637691
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
10. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
[TBL] [Abstract][Full Text] [Related]
11. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.
Vergadi E; Bitsori M; Maraki S; Galanakis E
J Pediatr Urol; 2017 Oct; 13(5):495.e1-495.e6. PubMed ID: 28341427
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
[TBL] [Abstract][Full Text] [Related]
13. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
Gregory CJ; Llata E; Stine N; Gould C; Santiago LM; Vazquez GJ; Robledo IE; Srinivasan A; Goering RV; Tomashek KM
Infect Control Hosp Epidemiol; 2010 May; 31(5):476-84. PubMed ID: 20334553
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Carbapenem-resistant
Wang Z; Qin RR; Huang L; Sun LY
Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
Simkins J; Muggia V; Cohen HW; Minamoto GY
Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
Vardakas KZ; Matthaiou DK; Falagas ME; Antypa E; Koteli A; Antoniadou E
J Infect; 2015 Jun; 70(6):592-9. PubMed ID: 25447713
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant Klebsiella pneumoniae acquisition in lung transplant recipients.
Raviv Y; Shitrit D; Amital A; Fox B; Bakal I; Tauber R; Bishara J; Kramer MR
Clin Transplant; 2012; 26(4):E388-94. PubMed ID: 22882693
[TBL] [Abstract][Full Text] [Related]
19. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Kalpoe JS; Sonnenberg E; Factor SH; del Rio Martin J; Schiano T; Patel G; Huprikar S
Liver Transpl; 2012 Apr; 18(4):468-74. PubMed ID: 22467548
[TBL] [Abstract][Full Text] [Related]
20. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
Qin X; Wu S; Hao M; Zhu J; Ding B; Yang Y; Xu X; Wang M; Yang F; Hu F
J Infect Dis; 2020 Mar; 221(Suppl 2):S206-S214. PubMed ID: 32176790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
